Breast Neoplasms: all 12,828 studies

Page 41 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.

• Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast CancerCompletedNCT01498458Phase 1Results posted
• HKI-272 for HER2-Positive Breast Cancer and Brain MetastasesCompletedNCT01494662Phase 2Results posted
• The BEACON Study (Breast Cancer Outcomes With NKTR-102)CompletedNCT01492101Phase 3Results posted
• A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerCompletedNCT01491737Phase 2Results posted
• Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation TherapyCompletedNCT01487954Phase 2Results posted
• Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast CancerTerminatedNCT01484041Phase 1/2Results posted
• An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 YearsCompletedNCT01480674Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted
• Vitamin D and Breast Cancer: Does Weight Make a Difference?TerminatedNCT01472445Phase 2Results posted
• Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast CancerCompletedNCT01471106Phase 2Results posted
• Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary CareCompletedNCT01468675Not applicableResults posted
• Reversing Hormone Resistance in Advanced Breast Cancer With PazopanibCompletedNCT01466972Phase 2Results posted
• Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionCompletedNCT01466270Phase 2Results posted
• Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01463072Phase 2Results posted
• Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast CancerCompletedNCT01463007Not applicableResults posted
• An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast CancerCompletedNCT01461044Results posted
• Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®CompletedNCT01448447Not applicableResults posted
• Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast CancerCompletedNCT01446159Phase 2Results posted
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)CompletedNCT01446016Phase 2Results posted
• Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast CancerCompletedNCT01441947Phase 2Results posted
• Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesCompletedNCT01441596Phase 2Results posted
• TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control RegistryCompletedNCT01440010Results posted
• Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerCompletedNCT01439945Phase 2Results posted
• Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast CancerCompletedNCT01439282Phase 2Results posted
• A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast CancerCompletedNCT01432886Phase 1Results posted
• A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective TumoursCompletedNCT01432145Phase 2Results posted
• Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast CancerTerminatedNCT01430585Phase 2Results posted
• A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerCompletedNCT01427933Phase 2Results posted
• Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone TherapyCompletedNCT01422408Phase 2Results posted
• A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerCompletedNCT01421472Phase 2Results posted
• Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin MetastasesCompletedNCT01421017Phase 1/2Results posted
• Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer PatientsCompletedNCT01420146Phase 1Results posted
• A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed TherapyCompletedNCT01419197Phase 3Results posted
• Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerCompletedNCT01417286Phase 2Results posted
• A Study of LY2523355 in Participants With Breast CancerCompletedNCT01416389Phase 2Results posted
• Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer SurvivorsCompletedNCT01414062Not applicableResults posted
• Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidTerminatedNCT01409811Not applicableResults posted
• Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast CancerCompletedNCT01401166Phase 2Results posted
• Fresolimumab and Radiotherapy in Metastatic Breast CancerCompletedNCT01401062Phase 2Results posted
• Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTerminatedNCT01394211Phase 2Results posted
• Vaccination of High Risk Breast Cancer PatientsCompletedNCT01390064Phase 1Results posted
• Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant TherapyTerminatedNCT01388777Phase 2Results posted
• Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast CancerTerminatedNCT01388647Phase 1/2Results posted
• Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic DiseaseCompletedNCT01387295Phase 2Results posted
• Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerCompletedNCT01385280Not applicableResults posted
• S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyCompletedNCT01385137Phase 3Results posted
• Nuevo Amanecer: Promoting the Psychosocial Health of LatinasCompletedNCT01383174Not applicableResults posted
• A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyCompletedNCT01381874Phase 2Results posted
• Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal SymptomsCompletedNCT01376349Phase 3Results posted
• Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerTerminatedNCT01368263Phase 2Results posted
• Proton Therapy for Lymph Nodes in Breast CancerCompletedNCT01365845Not applicableResults posted
• A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast CancerTerminatedNCT01363986Phase 2Results posted
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerCompletedNCT01358877Phase 3Results posted
• The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer PatientsTerminatedNCT01355523Phase 2/3Results posted
• LLLT Combined With CDT in Breast Cancer-Related LymphedemaCompletedNCT01351376Not applicableResults posted
• Azacitidine and Entinostat in Treating Patients With Advanced Breast CancerCompletedNCT01349959Phase 2Results posted
• Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryActive, not recruitingNCT01349322Phase 3Results posted
• Proton Radiation Therapy for Invasive Breast Cancer Following MastectomyCompletedNCT01340495Not applicableResults posted
• Exercise and Metformin in Colorectal and Breast Cancer SurvivorsCompletedNCT01340300Phase 2Results posted
• An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)CompletedNCT01332981Results posted
• TPI 287 in Breast Cancer Metastatic to the BrainCompletedNCT01332630Phase 2Results posted
• Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast CancerCompletedNCT01328249Phase 2Results posted
• Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast CancerCompletedNCT01326481Phase 1/2Results posted
• Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast CancerCompletedNCT01325428Phase 2Results posted
• Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast CancerCompletedNCT01325207Phase 1/2Results posted
• A Confirmation Study of Eribulin in Combination With CapecitabineCompletedNCT01323530Phase 1/2Results posted
• MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast CancerTerminatedNCT01319539Phase 2Results posted
• Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast CancerCompletedNCT01313039Early Phase 1Results posted
• A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast CancerCompletedNCT01310231Phase 2Results posted
• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast CancerCompletedNCT01307891Phase 2Results posted
• Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC PatientsCompletedNCT01306942Phase 1/2Results posted
• Phase II ABT-888 With CyclophosphamideCompletedNCT01306032Phase 2Results posted
• A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain MetastasesCompletedNCT01305941Phase 2Results posted
• A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ PatientsTerminatedNCT01305239Results posted
• Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast CancerTerminatedNCT01303419Not applicableResults posted
• Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer SurvivorsCompletedNCT01302379Not applicableResults posted
• A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin TreatmentCompletedNCT01301729Phase 4Results posted
• Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer WomenCompletedNCT01300351Phase 3Results posted
• Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast CancerCompletedNCT01299038Phase 2Results posted
• Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast CancerCompletedNCT01298362Results posted
• Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.CompletedNCT01298193Phase 4Results posted
• Effects of High Dose Calcitriol in Breast Cancer PatientsCompletedNCT01293682Phase 2Results posted
• Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancerCompletedNCT01293032Not applicableResults posted
• A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.TerminatedNCT01290718Phase 2Results posted
• Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver MetastasesCompletedNCT01290536Phase 2Results posted
• Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast CancerCompletedNCT01289353Phase 1/2Results posted
• Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsCompletedNCT01286987Phase 1Results posted
• Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07CompletedNCT01281137Results posted
• Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast CancerCompletedNCT01278212Not applicableResults posted
• Akt Inhibitor MK2206 in Treating Patients With Advanced Breast CancerCompletedNCT01277757Phase 2Results posted
• Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast CancerTerminatedNCT01276704Phase 2Results posted
• Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.TerminatedNCT01276054Phase 2Results posted
• Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast CancerCompletedNCT01276041Phase 2Results posted
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerCompletedNCT01275677Phase 3Results posted
• Open-label Study of STA-9090 for Patients With Metastatic Breast CancerCompletedNCT01273896Phase 2Results posted
• Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01273610Phase 2Results posted
• A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast CancerTerminatedNCT01272141Phase 2Results posted
• LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresCompletedNCT01271725Phase 2Results posted
• Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast CancerCompletedNCT01269346Phase 2Results posted
• A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast CancerCompletedNCT01268150Phase 2Results posted

← Breast Neoplasms overview